Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B579cfcc8b5b39208b31f6156c45b030c> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B579cfcc8b5b39208b31f6156c45b030c NCIT_P378 "NCI" @default.
- B579cfcc8b5b39208b31f6156c45b030c type Axiom @default.
- B579cfcc8b5b39208b31f6156c45b030c annotatedProperty IAO_0000115 @default.
- B579cfcc8b5b39208b31f6156c45b030c annotatedSource NCIT_C78487 @default.
- B579cfcc8b5b39208b31f6156c45b030c annotatedTarget "A cancer vaccine consisting of allogeneic neuroblastoma tumor cells have been genetically modified to secrete the human cytokine interleukin-2 (IL-2) and the human chemokine lymphotactin (Lptn) with potential immunostimulating and antineoplastic activities. Upon administration, IL-2 and Lptn are secreted by the IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine, potentially enhancing the cytotoxic T lymphocyte (CTL) response elicited by vaccine neuroblastoma tumor-associated antigens (TAAs) against host neuroblastoma tumor cells. Produced by activated progenitor T cells, Lptn belongs to the C chemokine subfamily and is a potent chemotactic factor for lymphocytes; IL-2 stimulates natural killer (NK) cells and may enhance a vaccine-elicited CTL immune response against tumor cells." @default.